NCT05542862View on ClinicalTrials.gov

Booster Study of SpikoGen COVID-19 Vaccine

PHASE3CompletedINTERVENTIONAL
Enrollment

81

Participants

Timeline

Start Date

September 7, 2022

Primary Completion Date

December 31, 2023

Study Completion Date

September 16, 2025

Conditions
COVID-19
Interventions
BIOLOGICAL

SpikoGen vaccine

Recombinant spike protein based Covid-19 vaccine

Trial Locations (1)

5042

ARASMI, Adelaide

Sponsors

Collaborators (1)

Cinnagen
All Listed Sponsors
collaborator

Australian Respiratory and Sleep Medicine Institute Ltd

UNKNOWN

collaborator

Cinnagen

INDUSTRY

lead

Vaxine Pty Ltd

INDUSTRY

NCT05542862 - Booster Study of SpikoGen COVID-19 Vaccine | Biotech Hunter | Biotech Hunter